Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

White paper on microbial anti-cancer therapy and prevention
Neil S. Forbes, Robert S. Coffin, Liang Deng, et al.
Journal for ImmunoTherapy of Cancer (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

Targeting metastatic cancer
Karuna Ganesh, Joan Massagué
Nature Medicine (2021) Vol. 27, Iss. 1, pp. 34-44
Open Access | Times Cited: 734
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Zong Sheng Guo, Binfeng Lu, Zongbi Guo, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 249
The cancer microbiome
Eran Elinav, Wendy S. Garrett, Giorgio Trinchieri, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 7, pp. 371-376
Open Access | Times Cited: 180
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer
Jenna H. Newman, Charles B. Chesson, Nora L. Herzog, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 117, Iss. 2, pp. 1119-1128
Open Access | Times Cited: 165
Promising dawn in tumor microenvironment therapy: engineering oral bacteria
Zifei Wang, Wansu Sun, Ruixue Hua, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 64
Exploiting bacteria for cancer immunotherapy
Seong Young Kwon, Hien Thi-Thu Ngo, Jinbae Son, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 8, pp. 569-589
Closed Access | Times Cited: 45
Genetically Engineered Microorganisms and Their Impact on Human Health
Marzie Mahdizade Ari, Leila Dadgar, Z Yad Elahi, et al.
International Journal of Clinical Practice (2024) Vol. 2024, pp. 1-38
Open Access | Times Cited: 19
Tweak to Treat: Reprograming Bacteria for Cancer Treatment
Brendan Fu‐Long Sieow, K.S. Wun, Wei Peng Yong, et al.
Trends in cancer (2020) Vol. 7, Iss. 5, pp. 447-464
Open Access | Times Cited: 111
Engineering probiotics for therapeutic applications: recent examples and translational outlook
Nikhil Aggarwal, Amy M. Ehrenworth Breedon, Christina M. Davis, et al.
Current Opinion in Biotechnology (2020) Vol. 65, pp. 171-179
Closed Access | Times Cited: 106
Immunobiology of cholangiocarcinoma
Emilien Loeuillard, Caitlin B. Conboy, Gregory J. Gores, et al.
JHEP Reports (2019) Vol. 1, Iss. 4, pp. 297-311
Open Access | Times Cited: 104
Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling
Anthony C. Antonelli, Anna Binyamin, Tobias M. Hohl, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 31, pp. 18627-18637
Open Access | Times Cited: 86
Customized materials-assisted microorganisms in tumor therapeutics
Qi‐Wen Chen, Ji‐Yan Qiao, Xinhua Liu, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 22, pp. 12576-12615
Closed Access | Times Cited: 70
Emerging applications of bacteria as antitumor agents
Vipin Chandra Kalia, Sanjay K. S. Patel, Byung‐Kwan Cho, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 1014-1025
Closed Access | Times Cited: 59
Listeria delivers tetanus toxoid protein to pancreatic tumors and induces cancer cell death in mice
Benson Chellakkan Selvanesan, Dinesh Chandra, Wilber Quispe‐Tintaya, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 637
Open Access | Times Cited: 55
Genetically engineered bacterium: Principles, practices, and prospects
Yiting Liu, Jing Feng, Hangcheng Pan, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 51
Dual drugs decorated bacteria irradiate deep hypoxic tumor and arouse strong immune responses
Wenfei Chen, Chun‐Ting He, Nan Qiao, et al.
Biomaterials (2022) Vol. 286, pp. 121582-121582
Closed Access | Times Cited: 46
Advances in Salmonella Typhimurium-based drug delivery system for cancer therapy
Wenfei Chen, Yining Zhu, Zhirong Zhang, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114295-114295
Closed Access | Times Cited: 39
Biopharmaceutical applications of microbial polysaccharides as materials: A Review
Yige Song, Shuxin Li, Gong Hao, et al.
International Journal of Biological Macromolecules (2023) Vol. 239, pp. 124259-124259
Closed Access | Times Cited: 32
ECM-targeting bacteria enhance chemotherapeutic drug efficacy by lowering IFP in tumor mouse models
Jisun Kim, Jam-Eon Park, Seung-Hyeon Choi, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 199-210
Open Access | Times Cited: 28
Microbes as Medicines: Harnessing the Power of Bacteria in Advancing Cancer Treatment
Shruti S. Sawant, Suyash M. Patil, Vivek Gupta, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7575-7575
Open Access | Times Cited: 59
Obligate and facultative anaerobic bacteria in targeted cancer therapy: Current strategies and clinical applications
Mateusz Dróżdż, Sebastian Makuch, Gabriela Cieniuch, et al.
Life Sciences (2020) Vol. 261, pp. 118296-118296
Closed Access | Times Cited: 58
Microbiota and Cancer: The Emerging Beneficial Role of Bifidobacteria in Cancer Immunotherapy
Giulia Longhi, Douwe van Sinderen, Marco Ventura, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 56
Pancreatic Cancer, Gut Microbiota, and Therapeutic Efficacy
Xiang Zhang, Qiaofei Liu, Quan Liao, et al.
Journal of Cancer (2020) Vol. 11, Iss. 10, pp. 2749-2758
Open Access | Times Cited: 52
Genetically engineered oncolytic bacteria as drug delivery systems for targeted cancer theranostics
Yu Chen, Xiaoqing Liu, Yanxia Guo, et al.
Acta Biomaterialia (2021) Vol. 124, pp. 72-87
Closed Access | Times Cited: 52
The role of bacteria and its derived biomaterials in cancer radiotherapy
Yu Zhang, Ruizhe Huang, Yunchun Jiang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 10, pp. 4149-4171
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top